960 x 350_41

Discovery Bioanalysis

Identifying candidates with promising ADME and pharmacokinetics properties during the discovery phase of drug development lays the groundwork for future clinical trials and regulatory approval. However, translating a long-term study into a successful outcome requires reliable, qualified measurements at a clinical scale.

 

Q2 Solutions’ global bioanalytical services network brings substantial expertise in biomarker assays and cell-based bioanalytical assays that target multi-domain proteins, antibodies, oligonucleotides, antibody-drug conjugates, and peptides.

 

Specific strengths include:

  • ADME assay development (including drug-drug interaction testing, discovery and development metabolite identification, and in vitro ADME screening)
  • Ligand-binding assays
  • Pharmacokinetic (PK) testing
  • Immunogenicity testing and immunoassays
  • Biomarker assays
  • Large molecule bioanalysis and LC/MS bioanalysis
  • DMPK services

Q² Solutions can work with you to develop automated small molecule LC/MS assays, large molecule ligand binding assays, immunoassays, and large-molecule hybrid-LC/MS assays to meet your discovery bioanalysis needs.

Q² Solutions can help you design and carry out validated assays that will move your project forward


Component 89 – 49

Assay Development for Large-Scale Clinical Studies

Supporting data from high-volume, regulated clinical studies

Component 89 – 50

Large Molecule Bioanalytical and ADME Solutions

Solutions for your large molecule bioanalysis and the successful outcome you seek

Related Thought Leaders Insights


Challenging Bioanalytical Work

If you’re looking for solutions to analytical challenges, you’ve come to the right place. Our highly trained scientists partner with you to provide a well-planned strategy, no matter where you are in...

Bioanalytical Testing & LC/MS/MS Analysis

Q2 Solutions is a leading drug discovery and development laboratory services organization with over 30 years of experience specializing in GLP-compliant bioanalytical testing. Our updated and...

A Process of Method Development for Tissue Homogenization and Analysis to Eliminate Binding and Matrix Effects Using Surrogate Matrices

The analysis and distribution of pharmaceuticals in tissue is increasingly important in understanding the full action of drugs in vivo. Across molecular types from very small molecules to larger...